Development of a novel monoclonal antibody with reactivity to a wide range of Venezuelan equine encephalitis virus strains

BACKGROUND: There is currently a requirement for antiviral therapies capable of protecting against infection with Venezuelan equine encephalitis virus (VEEV), as a licensed vaccine is not available for general human use. Monoclonal antibodies are increasingly being developed as therapeutics and are...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Brien, Lyn M, Underwood-Fowler, Cindy D, Goodchild, Sarah A, Phelps, Amanda L, Phillpotts, Robert J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783036/
https://www.ncbi.nlm.nih.gov/pubmed/19925641
http://dx.doi.org/10.1186/1743-422X-6-206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783036/
https://www.ncbi.nlm.nih.gov/pubmed/19925641
http://dx.doi.org/10.1186/1743-422X-6-206

Ejemplares similares